drugset / Trial / NCT03050086
Open Label Phase 2 Feasibility Study of BPX-04 Topical Minocycline Gel in Rosacea
Non-randomizedParallel-groupOpen-labelTreatment
Summary
An open label feasibility study using BPX-04 topical minocycline gel in papulopustular rosacea.
Timeline
- Start
- 2017-03-29
- Primary completion
- 2018-06-19
- Completion
- 2018-06-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Minocycline | Small molecule | 1 % | Topical |
| Subject | Minocycline | Small molecule | 2 % | Topical |